N-(3-(1H-Imidazol-1-yl)propyl)-N-(4,6-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride

Catalog No. :
ACCJQF945
CAS No. :
1217074-61-7
Molecular Formula :
C24H25ClN4O3S
Molecular Weight :
485.01

IUPAC Name:N-(3-(1H-imidazol-1-yl)propyl)-N-(4,6-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride

N-(3-(1H-Imidazol-1-yl)propyl)-N-(4,6-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(1H-Imidazol-1-yl)propyl)-N-(4,6-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride
IUPAC NameN-(3-(1H-imidazol-1-yl)propyl)-N-(4,6-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride
Molecular FormulaC24H25ClN4O3S
Molecular Weight485.01
SMILESO=C(C1COC2=CC=CC=C2O1)N(CCCN3C=CN=C3)C4=NC5=C(C)C=C(C)C=C5S4.[H]Cl
InChI KeyFVKPYDSVAFOEBH-UHFFFAOYSA-N
SynonymN-(4,6-dimethyl-1,3-benzothiazol-2-yl)-N-(3-imidazol-1-ylpropyl)-2,3-dihydro-1,4-benzodioxine-3-carboxamide:hydrochloride
CAS No.1217074-61-7

Synthetic Route by SureRoute

1. ACCJQF945 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCJQF945 route product structure diagram
    ACCJQF9451217074-61-7
Inquiry

2. ACCJQF945 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVSCI231 route compound structure diagram
    ACVSCI2313663-80-7 In Stock
  4. Then
  5. ACCJQF945 route product structure diagram
    ACCJQF9451217074-61-7
Inquiry

Comments (0)